Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial
Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays Revision: v3.5.0 and no longer displays Revision: v3.4.3.SummaryDifference0.0%

- Check23 days agoChange DetectedThe trial site list was updated to add Texas Children's Cancer and Hematology Center in Houston and a Calgary, Canada site (T3B6A8), and to remove the prior Calgary entry.SummaryDifference0.3%

- Check30 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this change does not affect study content, eligibility criteria, outcomes, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedFooter now shows Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.1%

- Check74 days agoChange DetectedThe study location entry for Phoenix Children's Hospital is updated to Phoenix Childrens Hospital, and the Last Update Posted label has changed from 'Last Update Posted (Estimated)' to 'Last Update Posted' with an updated date.SummaryDifference0.2%

Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.